International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 1396-1400
Research Article
Study Of Intra and Post-Operative Complications in Laparoscopic Inguinal Hernia Repair Using Total Extraperitoneal (TEP) Approach
 ,
 ,
Received
July 15, 2025
Accepted
Aug. 20, 2025
Published
Aug. 31, 2025
Abstract

Background: Inguinal hernias are common surgical conditions caused by a defect in the abdominal wall at the myopectineal orifice, an inherently weak collagenous region. Laparoscopic Transabdominal Preperitoneal (TAPP) repair, introduced by Arregui and Dion in the early 1990s, revolutionized hernia surgery, while the extraperitoneal approach is based on the Rives-Stoppa technique. However, TEP may be associated with higher rates of postoperative complications, Therefore, this study evaluates short- and mid-term intraoperative and postoperative complications of laparoscopic inguinal hernia repair using the TEP approach. Methods: Present study was longitudinal in nature conducted among 38 patients undergoing TEP repair. All patients fulfilling inclusion criteria and exclusion criteria were taken up for the study. Study was carried out over a period of 1.5 years. Results: Intraoperative complications included conversion to open surgery (23.68%), major vessel clipping (15.79%), pneumoperitoneum (13.16%), and troublesome bleeding (10.53%). Postoperatively, chronic pain showed a significant reduction across follow-up visits, with the highest incidence at one month (p < 0.05), while wound infection was significant immediately postoperatively (p < 0.05). Other complications showed no significant variation across the follow-up period (p > 0.05). Conclusion: Laparoscopic TEP repair for inguinal hernia demonstrated favorable perioperative outcomes, with acceptable operative time, manageable complications, and no recurrences or mortality during follow-up.

Keywords
INTRODUCTION

Inguinal hernias are common surgical conditions caused by a defect in the abdominal wall at the myopectineal orifice, an inherently weak collagenous region.1 The lifetime risk is approximately 27% in men and 3% in women.2 Surgical repair remains one of the most frequently performed procedures in general surgery.3

 

Laparoscopic Transabdominal Preperitoneal (TAPP) repair, introduced by Arregui and Dion in the early 1990s, revolutionized hernia surgery, while the extraperitoneal approach is based on the Rives-Stoppa technique.4 Current laparoscopic techniques include Totally Extraperitoneal (TEP), extended-view TEP (eTEP), TAPP, Intraperitoneal Onlay Mesh (IPOM), and sac reduction with or without ring closure, with classical TEP considered closest to the ideal repair, despite its technical complexity.

 

Recurrence and chronic pain remain the most significant mid-term complications.5 Systematic reviews show mixed outcomes when comparing laparoscopic and open anterior repair—some report similar complication rates,6 while others highlight advantages of laparoscopy, including reduced chronic inguinal pain7,8 and faster postoperative recovery.

 

However, TEP may be associated with higher rates of postoperative complications, including urinary retention, ileus, bowel obstruction, visceral and vascular injuries, or gas embolism, though reoperation rates are not proportionally increased.9 With growing experience among hernia surgeons in high-volume centres, outcomes are expected to improve. Therefore, this study evaluates short- and mid-term intraoperative and postoperative complications of laparoscopic inguinal hernia repair using the TEP approach.

 

OBJECTIVES

To study intra and post-operative complications in laparoscopic inguinal hernia repair using Total Extraperitoneal (TEP) approach.

 

MATERIALS AND METHODS

This prospective observational study was conducted at a tertiary care centre from January 2023 to June 2024. Adult patients (>18 years) presenting with uncomplicated inguinal hernia and undergoing laparoscopic repair using the Totally Extraperitoneal (TEP) approach were included. The study was approved by the Institutional Ethics Committee, and written informed consent was obtained from all participants.

 

Inclusion criteria comprised patients with good preoperative general condition, no significant comorbidities precluding general anaesthesia or pneumoperitoneum, and willingness to participate. Exclusion criteria included patients undergoing open hernia repair, pregnant women, those with absolute contraindications (e.g., intra-abdominal infection or abdominal wall fistula), obstructed or incarcerated hernias, age <18 years, and those unwilling to provide consent.

 

Preoperative assessment included demographic data, clinical history, and examination findings using a pre-structured proforma. Intraoperative variables recorded were side of hernia (unilateral/bilateral), blood loss, wound infection, organ injury, conversion to laparotomy, peritoneal closure technique, and complications. Postoperative evaluation included pain assessment using the Visual Analog Scale (VAS), incidence of complications, re-interventions, and duration of hospital stay. Relevant investigations such as haemoglobin, total and differential leukocyte counts, platelet count, haematocrit, abdominal ultrasonography, and urine examination were performed as needed. Perioperative antibiotic prophylaxis with intravenous Amoxiclav 1.2 g was administered at induction and continued up to three days postoperatively.

 

Sample size was calculated using Open EPI version 3.0, assuming a complication rate of 2.5% for chronic pain following laparoscopic TEP repair, with a 95% confidence level and 5% margin of error, resulting in a minimum sample size of 38. Convenience sampling was applied. Quantitative variables were presented as mean ± standard deviation (SD) and compared using the Z-test. Qualitative variables were analysed using Chi-square or Fisher’s exact test, as appropriate. A p-value <0.05 was considered statistically significant.

 

RESULTS

In this comparative longitudinal observational study of 38 patients with inguinal hernia undergoing laparoscopic repair via the total extraperitoneal (TEP) approach, intraoperative and postoperative outcomes were evaluated. The mean age of the study participants was 38.4 ± 8.9 years, with the majority (60.53%) aged 30–50 years, followed by 26.32% aged below 30 years and 13.15% aged above 50 years. All patients were male. Based on BMI classification, 39.47% were pre-obese (25–29.99 kg/m²), 34.21% had normal BMI (18–24.99 kg/m²), 21.06% were obese class I (30–34.99 kg/m²), and 5.26% were obese class II (35–39.99 kg/m²). Diabetes mellitus was the most frequent comorbidity (18.42%), followed by hypertension (2.63%), while 78.95% of patients had no comorbid conditions. All patients presented with inguinal swelling as the sole clinical complaint. Indirect hernia was predominant (76.32%), with bilateral involvement observed in 44.73% of patients, right-sided in 28.95%, and left-sided in 26.32%. The operative time ranged between 60 and 120 minutes, with a mean duration of 95.5 ± 17.7 minutes. Most procedures (68.42%) lasted 90–120 minutes, while 31.58% were completed within 60–90 minutes.

 

Intraoperative complications included conversion to open surgery (23.68%), major vessel clipping (15.79%), pneumoperitoneum (13.16%), and troublesome bleeding (10.53%). Postoperatively, chronic pain showed a significant reduction across follow-up visits, with the highest incidence at one month (p < 0.05), while wound infection was significant immediately postoperatively (p < 0.05). Other complications showed no significant variation across the follow-up period (p > 0.05).

 

VAS pain scores demonstrated a statistically significant decline over time (Repeated Measures ANOVA, p < 0.0001). The proportion of patients reporting no pain increased from 2.63% immediately after surgery to 92.11% at six months, while moderate-to-severe pain (VAS 4–9) decreased to zero by the third month (Cochran’s Q test, p < 0.0001).

 

Table 1. Distribution of patients according to baseline characteristics.

Baseline characteristic

No.

%

Age groups

30

10

26.32

30-50

23

60.53

>50

05

13.15

Mean + SD

38.4 + 8.9 years.

Gender

Male

38

100

Female

00

00

BMI

18-24.99

13

34.21

25-29.99

15

39.47

30-34.99

08

21.06

35-39.99

02

5.26

Comorbidities

Diabetes mellitus

07

18.42

Hypertension

01

2.63

   Nil

30

78.95

Type of inguinal hernia

Indirect

29

76.32

Direct

09

23.68

Laterality

Bilateral

17

44.73

Right

11

28.95

Left

10

26.32

 

 

Chart 1. Operative time wise distribution of cases.

 

Table 2. Distribution of cases according to intraoperative complications. (n=38)

Intraoperative complications

Cases

No.

 (%)

Conversion to open

09

23.68

Major vessel clipping

06

15.79

Pneumoperitoneum

05

13.16

Troublesome bleeding

04

10.53

 

Table 3. Comparison of cases according to postoperative complications at follow up of 1, 3 and 6 months. (n=38)

Postoperative complications

Follow up of cases

P#

Immediate

1 month

3 months

6 months

Chronic pain

20 (52.63)

25 (65.79)

10 (26.32)

03 (7.89)

<0.001

Mortality

00 (00)

00 (00)

00 (00)

00 (00)

--

Recurrence

00 (00)

00 (00)

00 (00)

00 (00)

--

Seroma

05 (13.16)

02 (5.26)

01 (2.63)

00 (00)

0.2

Wound infection

05 (13.16)

03 (7.89)

00 (00)

00 (00)

0.04

GI disturbance

29 (76.32)

00 (00)

00 (00)

00 (00)

--

#Cochran’s Q test

 

Table 4. Comparison of cases according to postoperative VAS pain scores.

Postoperative VAS

Pain scores

Follow up of cases

P

Immediate

1 month

3 months

6 months

 

0

01 (2.63)

13 (34.21)

28 (73.68)

35 (92.11)

 

 

 

<0.0001*

1-3

06 (15.79)

18 (47.37)

10 (26.32)

03 (7.89)

4-6

23 (60.53)

07 (18.42)

00 (00)

00 (00)

7-9

08 (21.05)

00 (00)

00 (00)

00 (00)

Total

38 (100)

38 (100)

38 (100)

38 (100)

Mean + SD

4.9 + 1.9

1.8 + 1.7

0.4 + 0.8

0.1 + 0.3

<0.0001#

* Cochran’s Q test p-value < 0.0001; # Anova repeated measure

 

DISCUSSION

This study assessed perioperative outcomes of laparoscopic TEP repair in 38 male patients (mean age 38.4 ± 8.9 years), consistent with Aggarwal et al.10 and Vineeth S et al,11 who also reported male predominance and peak incidence in the 31–40 years age group. Pre-obesity was the most frequent BMI category, comparable to Georgiou et al.12 Diabetes mellitus (18.42%) was the leading comorbidity, similar to Aggarwal et al.10

 

Indirect hernia was predominant (76.32%) with bilateral involvement in 44.73% of cases, aligning with Aggarwal et al.10 Mean operative time (95.5 ± 17.7 min) was comparable to Vineeth S et al.11 Conversion to open repair (23.68%) was the most common intraoperative complication, while postoperative issues were minor and self-limiting. VAS pain scores declined significantly (p < 0.0001), and 92.11% reported no pain at six months.

 

No recurrences or mortalities occurred, corroborating findings by Reiner et al.13 and Aggarwal et al.10 that TEP repair ensures safe and favourable outcomes.

 

CONCLUSION

Laparoscopic TEP repair for inguinal hernia demonstrated favorable perioperative outcomes, with acceptable operative time, manageable complications, and no recurrences or mortality during follow-up. Pain scores and postoperative morbidity significantly improved over time, supporting TEP as a safe and effective approach in appropriately selected patients. Further large-scale studies with long-term follow-up are recommended to validate these findings.

 

Declaration:

There was no source of funding in our study and there was no any conflict of interest.

 

REFERENCES

  1. Belyansky I, Tsirline VB, Klima DA, Walters AL, Lincourt AE, Heniford TB. Prospective, comparative study of postoperative quality of life in TEP, TAPP, and modifed Lichtenstein repairs. Ann Surg. 2011;254(5):709-14; discussion 714-5.
  2. Bittner R, Arregui ME, Bisgaard T, Dudai M, Ferzli GS, Fitzgibbons RJ, et al. Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia [International Endohernia Society (IEHS)]. Surg Endosc. 2011;25(9):2773 843.
  3. Bogros JA. Essay on the surgical anatomy of the iliac region and description of a new procedure for the ligation of the epigastric and external iliac arteries. Postgrad Gen Surg. 1995; 6:4-14.
  4. Heniford BT, Park A, Ramshaw BJ, Voeller G. Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg. 2003;238(3):391-9.
  5. Nienhuijs S, Staal E, Strobbe L, et al. Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 2007; 194:394–400.
  6. Koning GG, Wetterslev J, van Laarhoven CJHM, et al. The totally extraperitoneal method versus Lichtenstein’s technique for inguinal hernia repair: a systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. PLoS One 2013;8: e52599.
  7. Pisanu A, Podda M, Saba A, et al. Meta-analysis and review of prospective randomized trials comparing laparoscopic and Lichten stein techniques in recurrent inguinal hernia repair. Hernia 2015;19: 355–66.
  8. Yang J, Tong DN, Yao J, et al. Laparoscopic or Lichtenstein repair for recurrent inguinal hernia: a meta-analysis of randomized controlled trials. ANZ J Surg 2013; 83:312–8.
  9. Köckerling F, Bittner R, Jacob DA, et al. TEP versus TAPP: comparison of the perioperative outcome in 17,587 patients with a primary unilateral inguinal hernia. Surg Endosc 2015; 29:3750–60.
  10. Aggarwal P, Kochar MP, Sharma BK, Bansal A, Sharma S. A prospective study comparing intra-operative and postoperative complications in totally extra peritoneal repair vs extended totally extra peritoneal for inguinal hernia. 2024;11(10):1634–40.
  11. Vineeth S. Laparoscopic Management of Inguinal Hernia by TEP Technique - A Single Institution Experience. 2022; 3:4–8.
  12. Efi Georgiou, Schoina E, Markantonis S, Karalis V, Athanasopoulos PG, Chrysoheris P et al. Laparoscopic total extraperitoneal inguinal hernia repair. www.md-journal.com (2018) 97:52(e13974).
  13. Reiner MA, Bresnahan ER. Laparoscopic Total Extraperitoneal Hernia Repair Outcomes. JSLS. 2016;20(3).
Recommended Articles
Research Article Open Access
A Foe For Lung Is A Friend For Heart: Intrapericardial Bleomycin For Malignant Pericardial Effusion – A Case Series
2025, Volume-6, Issue-4 : 1410-1416
Research Article Open Access
A study of epidemiology of pityriasis rosea and therapeutic effect of narrow band ultra violet B phototheraphy on its course
2025, Volume-6, Issue-4 : 1381-1395
Research Article Open Access
Clinical Profile and Spectrum of Respiratory Disorders in Patients with Chronic Kidney Disease
2025, Volume-6, Issue-4 : 1296-1300
Research Article Open Access
Comparative Outcomes of Platelet-Rich Plasma and Autologous Blood Injection in Patients with Chronic Lateral Epicondylitis
2025, Volume-6, Issue-4 : 1314-1321
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue-4
Citations
9 Views
2 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved